期刊文献+

嗜铬细胞瘤与副神经节瘤患者左心室肥厚的临床意义 被引量:1

The clinical implication of left ventricular hypertrophy in patients with pheochromocytoma and paraganglioma
原文传递
导出
摘要 目的 探究嗜铬细胞瘤与副神经节瘤(PH/PGL)患者左心室肥厚的临床意义.方法 入选2010年10月至2013年4月就诊于北京协和医院的PH/PGL患者78例作为PH/PGL组,以无高血压、血糖异常、血脂异常病史,且X线胸片、心电图、超声心动图检查正常的健康者46例作为对照组.记录和分析患者的症状、体征、24h尿儿茶酚胺水平、心电图和超声心动图检查结果.结果 (1) PH/PGL组患者的左心室射血分数、心指数、左心室质量指数、左心房容积指数、二尖瓣血流舒张早期峰值流速(E)/二尖瓣环舒张早期峰值速度(E ')均高于对照组(P均<0.01),二尖瓣环侧壁侧E’低于对照组(P=0.012).(2)左心室肥厚PH/PGL患者病程中发生急性左心功能衰竭[12%(3/25)比0,P=0.030]、左心室射血分数持续下降[12% (3/25)比0,P=0.030]、心电图ST-T段改变[60% (15/25)比21%(11/53),P=0.0m]比例高于无左心室肥厚PH/PGL患者,左心房容积指数[(30.2±8.8) ml/m2比(23.8 ±4.7)ml/m2,P =0.007]、二尖瓣E/E’(11.2±6.0比7.2±1.4,P=0.003)高于无左心室肥厚PH/PGL患者,二尖瓣环间隔侧E’峰[(7.8±2.6)cm/s比(10.4±3.2)cm/s,P=0.001]与侧壁侧E '峰[(9.3±3.3)cm/s比(12.9±2.9)cm/s,P<0.001]、平均收缩峰[(7.9±1.6) cm/s比(8.8±1.7) cm/s,p=0.036]低于无左心室肥厚PH/PGL患者.(3)多元线性回归分析显示,年龄(t=3.491,P=0.001)、性别(t=2.899,P=0.005)、心率(t=2.255,P=0.027)、24 h尿去甲肾上腺素(t=3.369,P=0.001)为PH/PGL患者左心室质量指数的独立影响因素.结论 PH/PGL患者左心室肥厚与急性左心功能衰竭、左心室舒张功能障碍和左心室充盈压升高有关. Objective To explore the clinical implications of left ventricular hypertrophy (LVH) in patients with pheochromocytoma and paraganglioma(PH/PGL).Methods Seventy-eight PH/PGL patients receiving medical attention at Peking Union Medical College Hospital from October 2010 to April 2013 were included in the study.Forty-six healthy people who had no hypertension,pathoglycemia,dyslipidemia history,and with normal chest X-ray,electrocardiogram and echocardiography results served as control group.Clinical symptoms and signs,levels of 24-hour urinary catecholamine,electrocardiogram and echocardiography of participants were recorded and analyzed.Results (1) Left ventricular ejection fraction,cardiac output index,left ventricular mass index (LVMI),left atrial volume index (LAVI) and mitral E/E' were all significantly higher while mitral annulus lateral E' velocity was significantly lower in PH/PGL group than in control group(all P < 0.05).(2) LVH was associated with more prevalent acute left-sided heart failure episodes (12% (3/25)vs.0,P =0.030),sustained LVEF depression (12% (3/25) vs.0,P =0.030) and ECG ST-T segment alterations (60% (15/25) vs.21% (11/53),P =0.001) in PH/PGL patients.LAVI ((30.2 ± 8.8) ml/m2 vs.(23.8 ± 4.7) ml/m2,P =0.007) and mitral E/E' (11.2 ± 6.0 vs.7.2 ± 1.4,P =0.003) were significantly higher in patients with LVH than in patients without LVH.Mitral annulus septal ((7.8 ± 2.6) cm/s vs.(10.4 ± 3.2) cm/s,P =0.001) and lateral ((9.3±3.3) cm/s vs.(12.9±2.9)cm/s,P<0.001) E' velocity,averaged S' velocity((7.9 ± 1.6) cm/s vs.(8.8 ± 1.7) cm/s,P =0.036) were significantly lower in LVH patients comparing to patients without LVH.(3) According to multiple linear regression analysis,age (t =3.491,P =0.001),gender (t =2.899,P =0.005),heart rate (t =2.255,P =0.027),and 24-hour urinary norepinephrine level (t =3.369,P =0.001) were independent factors affecting LVMI of PH/PGL patients.Conclusion Left ventricular hypertrophy is associated with acute left-sided heart failure,left ventricular diastolic dysfunction and elevated left ventricular filling pressure in PH/PGL patients.
出处 《中华心血管病杂志》 CAS CSCD 北大核心 2014年第12期1029-1034,共6页 Chinese Journal of Cardiology
关键词 嗜铬细胞瘤 副神经节瘤 心脏扩大 Pheochromocytoma Paraganglioma Cardiomegaly
  • 相关文献

参考文献1

二级参考文献33

  • 1McMurray JJ,Adamopoulos S,Anker SD. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure,2012:The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure,2012 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association (HFA) of the ESC[J].{H}EUROPEAN HEART JOURNAL,2012.1787-1847.
  • 2Mosterd A,Hoes AW. Clinical epidemiology of heart failure[J].{H}HEART,2007.1137-1146.
  • 3Yancy CW,Jessup M,Bozkurt B. 2013 ACCF/AHAGuideline for the Management of Heart Failure:A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines[J].{H}Journal of the America College of Cardiology,2013.e147-e239.
  • 4Hogg K,Swedberg K,McMurray J. Heart failure with preserved left ventricular systolic function:epidemiology,clinical characteristics,and prognosis[J].{H}Journal of the America College of Cardiology,2004.317-327.
  • 5Yancy CW,Lopatin M,Stevenson LW. Clinical presentation,management,and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function:a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database[J].{H}Journal of the America College of Cardiology,2006.76-84.
  • 6Lee DS,Gona P,Vasan RS. Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction:insights from the Framingham heart study of the national heart,lung,and blood institute[J].{H}CIRCULATION,2009.3070-3077.
  • 7Bursi F,Weston SA,Redfield MM. Systolic and diastolic heart failure in the community[J].{H}JAMA:the Journal of the American Medical Association,2006.2209-2216.
  • 8Owan TE,Hodge DO,Herges RM. Trends in prevalence and outcome of heart failure with preserved ejection fraction[J].{H}New England Journal of Medicine,2006.251-259.
  • 9Hogg K,Swedberg K,McMurray J. Heart failure with preserved left ventricular systolic function, epidemiology,clinical characteristics,and prognosis[J].{H}Journal of the America College of Cardiology,2004.317-327.
  • 10Lam CS,Donal E,Kraigher-Krainer E. Epidemiology and clinical course of heart failure with preserved ejection fraction[J].{H}European Journal of heart failure,2011.18-28.

共引文献8

同被引文献4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部